FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

FDA Alert on Olympus Ligating Device Instructions

FDA issues a device correction alert after Olympus recalled (Class 1) the instructions for its Single Use Ligating Device PolyLoop, warning that impro...

latest-news-card-1

The Case for FDA Advisory Committees: Column

provals managing director Steven Cohen lists the many benefits of FDA advisory committees even as the agency has reduced its use of them significantly...

latest-news-card-1

Turalio Video Testimonial False or Misleading: OPDP

The CDER Office of Prescription Drug Promotion says a Daiichi Sankyo promotional video patient testimonial for its Turalio misleadingly creates the im...

latest-news-card-1
Human Drugs

Political Interference Prompted Pazdur Retirement: Peter Pitts

Former FDA associate commissioner Peter Pitts says CDER director Richard Pazdurs decision to abruptly retire was motivated by growing political interf...

latest-news-card-1
Biologics

Capricor Reports Data to Support Rejected Deramioce BLA

Capricor Therapeutics says Deramiocel, a cell therapy candidate targeting cardiomyopathy associated with Duchenne muscular dystrophy, achieved statist...

latest-news-card-1
Human Drugs

26 Rare Disease Drug Approvals in 2024: ARC Report

The CDER Accelerating Rare Disease Cures program Year-Three report shows a decline in new drug approvals and several other activities when compared wi...

latest-news-card-1
Medical Devices

American Hospital Association AI Policy Ideas

The American Hospital Association suggests ways for FDA to develop a regulatory framework for measuring and evaluating AI-enabled medical devices.

latest-news-card-1
Human Drugs

FDA Blocks Lawmakers from Attending Cancer Drug Meeting

A new Bloomberg report finds that two Republican lawmakers were barred from attending a 12/3 FDA meeting concerning the potential expanded approval of...

latest-news-card-1
Human Drugs

FDA Grants Full Approval to Lillys Jaypirca

FDA awards Eli Lilly traditional approval for Jaypirca (pirtobrutinib) and its use in adults with relapsed or refractory chronic lymphocytic leukemia ...

latest-news-card-1
Human Drugs

Integrate Key Teams for CNPV Success: Expert

Veristat principal regulatory specialist John Kirk outlines FDAs Commissioners National Priority Voucher program and how sponsors can succeed with the...